Login / Signup

Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant.

Sachin PunatarAniket MohiteAnant GokarnLingaraj NayakAvinash BondaKartthik ShanmugamKalasekhar VijaysekharanNavin Khattry
Published in: Bone marrow transplantation (2019)
Keyphrases
  • hematopoietic stem cell
  • low dose
  • bone marrow
  • drug induced
  • high dose